<DOC>
	<DOCNO>NCT02435836</DOCNO>
	<brief_summary>The primary objective study determine safety aripiprazole administer long-term dos range 10 30 mg per day maintenance therapy subject chronic first episode schizophrenia . Information continue efficacy aripiprazole also gather long-term trial ( 31 Dec 2012 aripiprazole otherwise available market mean and/or reimburse ) .</brief_summary>
	<brief_title>A Follow-on Study Long-Term Safety Aripiprazole Patients With Chronic Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>1 . Complete Prior Study : patient must meet one follow condition completion prior study : A patient complete 52 week postrandomization treatment prior double blind study ( 3197301 319830401 ) eligible , qualification . A patient earlyterminated study 3197301 3198 30401 either follow two reason eligible enter open label study minimal require duration prior doubleblind participation : Early termination due mark deterioration clinical status serious adverse event ( SAE ) hospitalization occur . The marked clinical deterioration must document least onepoint increase CGISeverity score baseline score 6 ( much bad ) 7 ( much bad ) CGIGlobal Improvement time termination , Early termination due nonserious AE require discontinuation study drug A patient early terminate minimum 4 week ' participation doubleblind treatment study 3197301 3198 30401 reason early termination withdrawal consent due lack effect mark deterioration . This must document change baseline CGISeverity score score 4 ( change ) 5 ( minimally bad ) CGIGlobal Improvement scale . 2 . Signing Informed Consent Form : Prior procedure drug administration , patient must sign informed consent form . In addition , require Ethical Committee , patient 's nextofkin responsible caregiver cosign patient 's consent form separate consent form . 1 . Patients suffer significant somatic disease medical problem would obscure result treatment , might require frequent change concomitant medication . 2 . Patients acute unstable medical condition require pharmacotherapy , schizophrenia . 3 . Patients abnormal laboratory test value recent analysis ( study 3197301 319830401 ) consider investigator present significant risk patient continue treatment aripiprazole . 4 . Patients earlyterminated prior doubleblind study ( 3197301 319830401 ) due serious adverse event ( SAE ) worsen psychosis hospitalization . 5 . Female patient child bear potential positive serum pregnancy test baseline ( last visit prior study ) openlabel followon study . 6 . Patients positive result urine screen drug abuse ( except cannabis medicallyprescribed analgesic benzodiazepine . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>